Genexine's cervical cancer therapeutic vaccine GX-188E
Published on Lancet_Oncology Nov. 2020
Keytruda®(Pembrolizumab) combination therapy with GX-188E therapeutic DNA vaccine (KEYNOTE-567)
in patients with advanced cervical cancer was published in Lancet Oncology.